Literature DB >> 21129347

Analysis of point-of-care and over-the-counter testing methods for hemoglobin A1c: how good do they need to be?

Randie R Little1.   

Abstract

In this issue of Journal of Diabetes Science and Technology, Chang and colleagues evaluate the performance of the A1CNow® SELFCHECK device for measurement of hemoglobin A1c (HbA1c). The authors discuss the potential advantages of point-of-care (POC) HbA1c testing and also mention the importance of accuracy and precision and provide some data to document the device's performance. There are specific criteria for HbA1c method evaluation and proficiency testing used by the National Glycohemoglobin Standardization Program and the College of American Pathologists. Chang and colleagues mention these criteria but chose wider performance limits for their evaluation of the A1cNow SELFCHECK. Given the available data on the relationship between HbA1c and risk for complications, assay method performance is a vital consideration when HbA1c results, including those from POC methods, are used in the management of patients with diabetes.
© 2010 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129347      PMCID: PMC3005062          DOI: 10.1177/193229681000400626

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  7 in total

1.  Tests of glycemia in diabetes.

Authors:  David E Goldstein; Randie R Little; Rodney A Lorenz; John I Malone; David M Nathan; Charles M Peterson
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  Evaluation of an over-the-counter glycated hemoglobin (A1C) test kit.

Authors:  Anna Chang; Joy Frank; Jennifer Knaebel; Jeanellen Fullam; Scott Pardo; David A Simmons
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

3.  Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods.

Authors:  William L Roberts; Sekineh Safar-Pour; Barun K De; Curt L Rohlfing; Cas W Weykamp; Randie R Little
Journal:  Clin Chem       Date:  2005-02-03       Impact factor: 8.327

4.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.

Authors:  Helena W Rodbard; Lawrence Blonde; Susan S Braithwaite; Elise M Brett; Rhoda H Cobin; Yehuda Handelsman; Richard Hellman; Paul S Jellinger; Lois G Jovanovic; Philip Levy; Jeffrey I Mechanick; Farhad Zangeneh
Journal:  Endocr Pract       Date:  2007 May-Jun       Impact factor: 3.443

5.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

6.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

  7 in total
  1 in total

1.  Selecting an A1C Point-of-Care Instrument.

Authors:  Heather P Whitley; Ee Vonn Yong; Casey Rasinen
Journal:  Diabetes Spectr       Date:  2015-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.